Graindorge A et al. (2008), Identification of CUG-BP1/EDEN-BP target mRNAs ...

XB-ART-37244

Nucleic Acids Res 2008 Apr 01;366:1861-70. doi: 10.1093/nar/gkn031.

Show Gene links Show Anatomy links

Identification of CUG-BP1/EDEN-BP target mRNAs in Xenopus tropicalis.

Graindorge A , Le Tonquèze O , Thuret R , Pollet N , Osborne HB , Audic Y .

???displayArticle.abstract???
The early development of many animals relies on the posttranscriptional regulations of maternally stored mRNAs. In particular, the translation of maternal mRNAs is tightly controlled during oocyte maturation and early mitotic cycles in Xenopus. The Embryonic Deadenylation ElemeNt (EDEN) and its associated protein EDEN-BP are known to trigger deadenylation and translational silencing to several mRNAs bearing an EDEN. This Xenopus RNA-binding protein is an ortholog of the human protein CUG-BP1/CELF1. Five mRNAs, encoding cell cycle regulators and a protein involved in the notch pathway, have been identified as being deadenylated by EDEN/EDEN-BP. To identify new EDEN-BP targets, we immunoprecipitated EDEN-BP/mRNA complexes from Xenopus tropicalis egg extracts. We identified 153 mRNAs as new binding targets for EDEN-BP using microarrays. Sequence analyses of the 3' untranslated regions of the newly identified EDEN-BP targets reveal an enrichment in putative EDEN sequences. EDEN-BP binding to a subset of the targets was confirmed both in vitro and in vivo. Among the newly identified targets, Cdk1, a key player of oocyte maturation and cell cycle progression, is specifically targeted by its 3' UTR for an EDEN-BP-dependent deadenylation after fertilization.

???displayArticle.pubmedLink??? 18267972
???displayArticle.pmcLink??? PMC2330240
???displayArticle.link??? Nucleic Acids Res

Species referenced: Xenopus tropicalis
Genes referenced: aurka cdk1 celf1 gnl3 kif11 notch1 psmd6 s100a1 tbx2

???attribute.lit??? ???displayArticles.show???

	Figure 1. EDEN-BP antibodies and IP specificities. (A) Î±E1- and Î±E2-purified polyclonal antibodies were used to detect endogenous EDEN-BP in crude UFE extracts. Protein size (kiloDalton) are indicated on the left side of the panel. The arrowhead indicates EDEN-BP. (B) Western blot analysis of EDEN-BP/RNA complexes immunopurified from UFE extract with control IgG, Î±E1 or Î±E2 antibodies as indicated. Input indicates initial sample (1/7.5). Detection is realized with a guinea pig antibody raised against recombinant EDEN-BP. (C) Detection by RT-PCR of the mRNA recovered from the IP eluates presented in B. The tested mRNAs are indicated on the right of the panel. Input is the original UFE extract and RTâ corresponds to control reaction with input RNA and no reverse transcriptase.
	Figure 2. Overrepresentation of the EDEN15 motif in the 3â²UTR of mRNAs complexed to EDEN-BP. (A) MEME analysis of 62 sequences binding EDEN-BP in vitro identified 39 times a 15 nt motif (EDEN15) in 37 sequences (out of 62). These 39 motifs were aligned and used to generate the EDEN15 motif represented here as a sequence logo. (B) Occurences of mRNAs bearing the EDEN15 motif at a given score in the 3â² UTR from identified target mRNAs and control datasets. UTR_array corresponds to all the 3â² UTR available for mRNAs represented on the microarray. UTR_target corresponds to all the 3â² UTR available for the identified EDEN-BP target mRNAs. UTR_target_Rev corresponds to the reverse complement of the UTR_target dataset. UTR_Target_Shuffle corresponds to the UTR_Target dataset after shuffling of the sequences.
	Figure 3. EMSA for eight new EDEN-BP target mRNAs. (A) Based on the study by Graindorge et al. (34), inferred adenylation changes for the RNA tested in bandshift. (â) Indicates a decrease and (+) indicates an increase in the poly(A)+ signal of at least 10% after fertilization for the indicated RNA. 0 Indicates an absence of adenylation change. (B) Two representative EMSA with recombinant EDEN-BP and the indicated RNAs are shown; 3â² Eg5C6 is a negative control and ZMPste 24 is a new EDEN-BP target RNA. C1 and C2 indicates the two different complexes formed by multimerization of EDEN-BP, F indicates the free probe, the rEDEN-BP concentrations are indicated on top of each lane. (C) Apparent Kd (nanomolar) and standard deviation was calculated from three different EMSA experiments for each of the indicated RNAs.
	Figure 4. Binding of endogenous EDEN-BP protein to newly identified target RNAs. The indicated RNAs were tested for their ability to bind endogenous EDEN-BP protein by UV crosslinking. (A) The radiolabeled proteins were separated by SDSâPAGE and revealed using a Phosphorimager. (B) UV-crosslinking experiment in presence of specific (S) or non-specific (NS) unlabeled competitor. E corresponds to extract only, NS 100 corresponds to a binding realized in presence of 100-fold excess of non-specific competitor (3â² Eg5C6), S10 and S100 correspond to binding realized in the presence, respectively, of 10- and 100-fold excess of EDEN-BP-specific competitor (3â² Eg5). The arrowhead indicates the EDEN-BP position.
	Figure 5. Cdk1 3â² UTR target a reporter mRNA for EDEN-BP-dependent deadenylation in Xenopus embryos. (A) The indicated capped poly(A)+ and radiolabeled mRNAs (ORF-Cdk1, ORF-AurA) were injected into two-cell embryos and samples were harvested at the indicated time after injection (hpi). Total RNA were extracted and separated by denaturing polyacrylamide gel electrophoresis. Radiolabeled RNAs were revealed by Phosphorimaging. For ORF-Cdk1, one can observe a small smiling of the gel. (B) ORF-Cdk1 mRNA was coinjected with either Î±E2 (antiEDEN-BP) antibody or control IgG as indicated. Samples were harvested at the indicated time after injection. Radiolabeled RNAs were analyzed as described for A). RNA size markers are positioned on the left side of the panel. The asterisk (*) denote the position of the poly(A)â mRNAs.

References [+] :

Audic, Embryo deadenylation element-dependent deadenylation is enhanced by a cis element containing AUU repeats. 1998, Pubmed, Xenbase